Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Clarivate › Director received an award of 62K CLVT shares Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date May 14, 2026
Reporting period Not applicable
Filed with the SEC May 16, 2026 Director Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001764046-26-000067
Filed / recorded
May 16, 2026, 2:26 AM UTC
Added to OQRO Oct 7, 2026, 10:28 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Andrew Miles Snyder
Table Non-derivative (Table I)
Transaction date May 14, 2026
Acquired / disposed Acquired (A)
Shares owned after 270,703
Footnotes from the filing Annual non-employee director award of restricted share units granted pursuant to the Clarivate Plc Amended and Restated 2019 Incentive Award Plan.
Around the same time Federal contracts
Homeland Security awardedUpdated 6mo ago Computer assisted legal research (CALR) solution.
The Department of Homeland Security has committed $5.44M to Clarivate so far. The contract could grow to $17.3M. It runs until Apr 1, 2027.
Federal contracts
License plate reader platform access
The Department of Justice has committed $777K to Clarivate so far. The contract could grow to $4.13M. It runs until Feb 28, 2027.
Insider filing
Traded May 13 · filed 3 days later
Routine share withholding; mechanical by default.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Dec 31, 2025 Federal contract · $5.9M obligated Department of the Treasury awarded CLARIVATE PLC: $5.93M obligated to date Jan 28, 2026 Federal contract · $1.3M obligated Department of Commerce awarded CLARIVATE PLC: $1.29M obligated to date Feb 26, 2026 Federal contract · $777K obligated Department of Justice awarded CLARIVATE PLC: $777K obligated to date Mar 23, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On March 23, 2026, the Board of Directors (the “Board”) of Clarivate Plc (the “Company”), upon the recommendation of the Human Resources and Compensation Committee of the Board (the “HRCC”), approved the adoption of the Amended and Restated Executive Severance Plan of Clarivate Plc (the “A&R Executive Severance Plan”), effective March 23, 2026.” Mar 31, 2026 Federal contract · $2.4M obligated Department of Homeland Security awarded CLARIVATE PLC: $2.4M obligated to date Apr 2, 2026 Federal contract · $5.4M obligated Department of Homeland Security awarded CLARIVATE PLC: $5.44M obligated to date Apr 6, 2026 Federal contract · $696K obligated Department of Agriculture awarded CLARIVATE PLC: $696K obligated to date Apr 29, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors What came next Jun 5, 2026 Company filing · Form 8-K · Executive change, Reg FD Changed a top executive or board member, and shared information with investors “Maroun S. Mourad, President, Intellectual Property of Clarivate Plc (the “Company”) will depart from his position, effective June 9, 2026. Following such date, Mr. Mourad will remain employed by the Company in a non-executive advisory role until September 30, 2026.” Jul 3, 2026 Company filing · Form 8-K · Material agreement, Executive change Changed a top executive or board member, and signed an important agreement “On July 3, 2026, a subsidiary of Clarivate entered into a retention agreement with Henry Levy, Clarivate’s President, Life Sciences & Healthcare, to encourage his continued commitment toward the completion of the Transaction.” Jul 24, 2026 Company filing · Form 8-K · Executive change, Reg FD Changed a top executive or board member, and shared information with investors “On July 24, 2026, Jonathan Collins, the Executive Vice President & Chief Financial Officer of Clarivate Plc (the “Company”) resigned from his position, effective August 7, 2026.”